The global urology surgical instruments market is expected to reach USD 11.48 Billion by 2021 from USD 7.74 Billion in 2016, growing at a CAGR of 8.2% from 2016 to 2021. The growth of the overall urology surgical instruments market can be contributed to rising prevalence of kidney diseases and urinary tract infections; rising number of hospitals and growing hospital investments in surgical infrastructure; availability of investments, funds, and grants from government bodies; and rising geriatric population.
n this report, the urology surgical instruments market has been segmented on the basis of product, and application. On the basis of product, the urology surgical instruments market is categorized into urology endoscopes, endovision systems, peripheral instruments, and consumables and accessories.
The increasing number of conferences further assist the growth of the APAC urology surgical instrument industry. Conference Series LLC company organizes conferences for various company’s delegates and students. For instance, it is going organize the 15th international conference on nephrology and hypertension from 22nd April-23rd April 2019 in Kuala Lumpur, Malaysia. This event is expected to include topics such as clinical nephrology, CKDs, dialysis and recent renal therapies, nephrology and hypertension, nephrotic syndrome, and renal failure. Thus, the increase in conferences is expected to create awareness among urologic surgeons to understand kidney disorders more practically.
Major players in the urology surgical instruments market include Olympus Corporation (Japan), KARL STORZ GmbH & Co. KG (Germany), Richard WOLF GmbH (Germany), Coloplast A/S (Denmark), Cook Medical Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), Teleflex incorporated (U.S.), Stryker Corporation (U.S.), CooperSurgical, Inc. (U.S.), and ConMed Corporation (U.S.).
Comments
Post a Comment